tetano
Editor, Senior Moderator
Virol Sin
. 2025 May 17:S1995-820X(25)00059-8.
doi: 10.1016/j.virs.2025.05.001. Online ahead of print. Characterization of a SARS-CoV-2 Infection Model in Golden Hamsters with Diabetes Mellitus
Hao-Feng Lin[SUP] 1 [/SUP], Ren-Di Jiang[SUP] 2 [/SUP], Rui-Xin Qin[SUP] 3 [/SUP], Bing Yao[SUP] 4 [/SUP], Wen-Tao Zeng[SUP] 3 [/SUP], Yun Gao[SUP] 5 [/SUP], Ai-Min Shi[SUP] 6 [/SUP], Jian-Min Li[SUP] 7 [/SUP], Mei-Qin Liu[SUP] 8 [/SUP]
Affiliations
Being widespread across the globe, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) keeps evolving and generating new variants and continuously poses threat to public health, especially to the population with chronic comorbidities. Diabetes mellitus is one of high-risk factors for severe outcome of coronavirus disease 2019 (COVID-19). Establishment of animal models that parallel the clinical and pathological features of COVID-19 complicated with diabetes is thus highly essential. Here, in this study, we constructed leptin receptor gene knockout hamsters with the phenotype of diabetes mellitus (db/db), and revealed that the diabetic hamsters were more susceptible to SARS-CoV-2 and its variants than wild-type hamsters. SARS-CoV-2 and its variants induced a stronger immune cytokine response in the lungs of diabetic hamsters than in wild-type hamsters. Comparative histopathology analyses also showed that infection of SARS-CoV-2 and the variants caused more severe lung tissue injury in diabetic hamsters, and may induce serious complications such as diabetic kidney disease and cardiac lesions. Our findings demonstrated that despite the decreased respiratory pathogenicity, the SARS-CoV-2 variants were still capable of impairing other organs such as kidney and heart in diabetic hamsters, suggesting that the risk of evolving SARS-CoV-2 variants to diabetic patients should never be neglected. This hamster model may help better understand the pathogenesis mechanism of severe COVID-19 in patients with diabetes. It will also aid in development and testing of effective therapeutics and prophylactic treatments against SARS-CoV-2 variants among these high-risk populations.
Keywords: diabetes; hamster; multiorgan injury; pneumonia; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
. 2025 May 17:S1995-820X(25)00059-8.
doi: 10.1016/j.virs.2025.05.001. Online ahead of print. Characterization of a SARS-CoV-2 Infection Model in Golden Hamsters with Diabetes Mellitus
Hao-Feng Lin[SUP] 1 [/SUP], Ren-Di Jiang[SUP] 2 [/SUP], Rui-Xin Qin[SUP] 3 [/SUP], Bing Yao[SUP] 4 [/SUP], Wen-Tao Zeng[SUP] 3 [/SUP], Yun Gao[SUP] 5 [/SUP], Ai-Min Shi[SUP] 6 [/SUP], Jian-Min Li[SUP] 7 [/SUP], Mei-Qin Liu[SUP] 8 [/SUP]
Affiliations
- PMID: 40389095
- DOI: 10.1016/j.virs.2025.05.001
Being widespread across the globe, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) keeps evolving and generating new variants and continuously poses threat to public health, especially to the population with chronic comorbidities. Diabetes mellitus is one of high-risk factors for severe outcome of coronavirus disease 2019 (COVID-19). Establishment of animal models that parallel the clinical and pathological features of COVID-19 complicated with diabetes is thus highly essential. Here, in this study, we constructed leptin receptor gene knockout hamsters with the phenotype of diabetes mellitus (db/db), and revealed that the diabetic hamsters were more susceptible to SARS-CoV-2 and its variants than wild-type hamsters. SARS-CoV-2 and its variants induced a stronger immune cytokine response in the lungs of diabetic hamsters than in wild-type hamsters. Comparative histopathology analyses also showed that infection of SARS-CoV-2 and the variants caused more severe lung tissue injury in diabetic hamsters, and may induce serious complications such as diabetic kidney disease and cardiac lesions. Our findings demonstrated that despite the decreased respiratory pathogenicity, the SARS-CoV-2 variants were still capable of impairing other organs such as kidney and heart in diabetic hamsters, suggesting that the risk of evolving SARS-CoV-2 variants to diabetic patients should never be neglected. This hamster model may help better understand the pathogenesis mechanism of severe COVID-19 in patients with diabetes. It will also aid in development and testing of effective therapeutics and prophylactic treatments against SARS-CoV-2 variants among these high-risk populations.
Keywords: diabetes; hamster; multiorgan injury; pneumonia; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).